LLY, ABBV Stocks Hit All-Time High – Here’s What’s Driving Investor Enthusiasm Today
LLY, ABBV Stocks Hit All-Time High – Here’s What’s Driving Investor Enthusiasm Today Yahoo Finance
Covered in this story
What has happened since
- Lilly (Eli) is down 3.4% since this was published, 6 days ago.
- AbbVie is down 1.7% since this was published, 6 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Lilly (Eli)
- Freedom Broker: $1.42k → $1.6k by Oct 2027 · Buy via Investing.com
- Bernstein: $1.42k → $1.45k by Oct 2027 · Outperform via Investing.com
- Cantor Fitzgerald: $1.19k → $1.44k by Oct 2027 · Overweight via Stocktwits
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $LLY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Lilly (Eli) →Dalsna Finance is currently tracking 6 stories mentioning Lilly (Eli), the earliest published 9 Sept 2026.
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.